Close Menu

NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Monday that its revenues for the first quarter of fiscal year 2019 fell 21 percent year over year.

For the three months ended Oct. 31, the firm reported total revenues of $21.3 million, down from $26.9 million in Q1 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.